Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.010 GeneticVariation disease BEFREE The TBL1Y(A) USP9Y(A) haplotype of the Y chromosome, present only in black people of African origin, attributes a favorable lipoprotein pattern, likely to contribute to their reduced susceptibility to coronary heart disease. 18511697 2008
CUI: C0021364
Disease: Male infertility
Male infertility
0.140 GeneticVariation phenotype LHGDN Tracking microdeletions of the AZF region in a patrilineal line of infertile men. 18752188 2008
CUI: C0004509
Disease: Azoospermia
Azoospermia
0.140 Biomarker disease BEFREE The association of this large deletion with normal fertility shows that USP9Y, hitherto considered a candidate gene for infertility and azoospermia, does not have a key role in male reproduction. 19246359 2009
CUI: C0028960
Disease: Oligospermia
Oligospermia
0.130 GeneticVariation disease BEFREE Deletions in the azoospermia factor region AZFa on the human Y chromosome and, more specifically, in the region that encompasses the ubiquitin-specific peptidase 9, Y-linked gene USP9Y have been implicated in infertility associated with oligospermia and azoospermia. 19246359 2009
CUI: C1507149
Disease: Partial chromosome Y deletion
Partial chromosome Y deletion
0.300 ChromosomalRearrangement phenotype ORPHANET Genetic dissection of the AZF regions of the human Y chromosome: thriller or filler for male (in)fertility? 20671934 2010
Male sterility due to Y-chromosome deletions
0.300 ChromosomalRearrangement phenotype ORPHANET Genetic dissection of the AZF regions of the human Y chromosome: thriller or filler for male (in)fertility? 20671934 2010
CUI: C1507149
Disease: Partial chromosome Y deletion
Partial chromosome Y deletion
0.300 ChromosomalRearrangement phenotype ORPHANET Screening for partial AZFa microdeletions in the Y chromosome of infertile men: is it of clinical relevance? 22537385 2012
Male sterility due to Y-chromosome deletions
0.300 ChromosomalRearrangement phenotype ORPHANET Screening for partial AZFa microdeletions in the Y chromosome of infertile men: is it of clinical relevance? 22537385 2012
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.020 AlteredExpression disease BEFREE USP9Y-TTTY15 expression is neither higher in cancer than adjacent normal tissues, nor correlated with features of advanced prostate cancer. 25188740 2014
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.020 AlteredExpression disease BEFREE USP9Y-TTTY15 expression is neither higher in cancer than adjacent normal tissues, nor correlated with features of advanced prostate cancer. 25188740 2014
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.010 AlteredExpression group BEFREE USP9Y-TTTY15 expression is neither higher in cancer than adjacent normal tissues, nor correlated with features of advanced prostate cancer. 25188740 2014
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.010 AlteredExpression group BEFREE USP9Y-TTTY15 expression is neither higher in cancer than adjacent normal tissues, nor correlated with features of advanced prostate cancer. 25188740 2014
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.020 AlteredExpression disease BEFREE Real-time quantitative polymerase chain reaction was performed to evaluate the expression of TTTY15-USP9Y and the prostate cancer-specific antigen (PSA) level. 26008593 2015
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.020 AlteredExpression disease BEFREE Real-time quantitative polymerase chain reaction was performed to evaluate the expression of TTTY15-USP9Y and the prostate cancer-specific antigen (PSA) level. 26008593 2015